Nomad Foods Reports Fourth Quarter and Full Year 2023 Financial Results
Delivers record-high net sales and Adjusted EBITDA; Full year Adjusted EPS of €1.61
Affirms strong 2024 financial guidance
FELTHAM,
The Company finished the year on excellent footing and given the ongoing sequential improvement in its monthly trends, the business is on track to return to positive volume growth in 2024.
Key operating highlights and financial performance for the fourth quarter 2023, when compared to the fourth quarter 2022, include:
- Reported revenue increased 1.4% to €761 million
- Organic revenue growth of 1.9%
- Adjusted EBITDA up 3.2% to €117 million
- Adjusted EPS of €0.32
Key operating highlights and financial performance for the full year 2023, when compared to the full year 2022, include:
- Reported revenue increased 3.6% to €3.0 billion
- Organic revenue growth of 4.9%
- Adjusted EBITDA increased 2.0% to €535 million
- Adjusted EPS of €1.61
- Adjusted free cash flow of €300 million, representing an adjusted free cash flow conversation of 109%
2024 full year guidance
For the full year 2024, the Company expects organic net revenue growth of 3%-4%, driven by positive volume/mix, adjusted EBITDA growth of 4%-6%, and adjusted EPS of €1.75-€1.80, implying growth of 9-12%. Based on USD/EUR exchange rate as of
Management Comments
Stéfan Descheemaeker,
"Looking ahead to 2024, I am even more excited about our continued momentum as we return to our normal operating cadence. Frozen food consumption trends are rebounding, and we are well-positioned to deliver attractive organic growth as we sharpen our innovation focus and raise our marketing and brand investments. We are elevating our productivity agenda and aggressively managing costs, which, coupled with our effective capital allocation, positions us to generate stronger bottom-line growth and superior shareholder returns over the long-term."
Fourth Quarter of 2023 results compared to the Fourth Quarter of 2022
- Revenue increased 1.4% to €761 million. Organic revenue increase of 1.9% was driven by a 7.5% increase in price offset by a 5.6% decline in volume/mix.
- Gross profit increased 8% to €208 million. Gross margin increased 160 basis points to 27.3% driven by a favorable comparison in the timing of pricing delivery in the prior year.
- Adjusted operating expenses increased 14% to €117 million due to increased A&P investment in the business.
- Adjusted EBITDA increased by 3.2% to €117 million and Adjusted Profit after tax decreased 9% to €52 million due to higher interest charges.
- Adjusted EPS decreased 3.0% to €0.32, reflecting the decrease in Adjusted Profit after tax due to higher interest charges. Reported EPS decreased 29% to €0.15.
Year Ended 2023 results compared to the Year Ended 2022
- Revenue increased 3.6% to €3,045 million. Organic revenue increase of 4.9% was driven by a 14.4% increase in price offset by a 9.5% decline in volume/mix.
- Gross profit increased 5% to €859 million. Gross margin increased 50 basis points to 28.2% linked to the successful recovery of higher input costs through pricing and a benefit in the cost of goods sold from the tail end of our cover positions from 2022.
- Adjusted operating expenses increased 10% to €419 million due to increased A&P investment in the business.
- Adjusted EBITDA increased 2% to €535 million and Adjusted Profit after tax decreased 6% to €275 million, due to higher interest charges.
- Adjusted EPS decreased 4.2% to €1.61, reflecting the decrease in Adjusted Profit after tax due to higher interest charges. Reported EPS decreased 21% to €1.13.
Conference Call and Webcast
The Company will host a conference call with members of the executive management team to discuss these results today,
Enquiries
Investor Relations Contact
amit.sharma@nomadfoods.com
Media Relations Contact
Collected Strategies
nomad-cs@collectedstrategies.com
+1-617-3124937; +1-917-3466841
About
Non-IFRS Financial Information
Adjusted financial information for the three and twelve months ended
Adjusted EBITDA is profit or loss for the period before taxation, net financing costs, depreciation and amortization, adjusted to exclude, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges and other unusual or non-recurring items. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted EBITDA provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.
Adjusted EBITDA should not be considered as an alternative to profit/(loss) for the period, determined in accordance with IFRS, as an indicator of the Company's operating performance.
Adjusted Profit for the period is defined as profit for the period excluding, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, unissued preferred share dividends, as well as certain other items considered unusual or non-recurring in nature. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted Profit after tax provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.
Adjusted EPS is defined as diluted earnings per share excluding, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, as well as certain other items considered unusual or non-recurring in nature. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted EPS provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.
Organic revenue growth/(decline) is an adjusted measurement of our operating results. The comparison for the three and twelve months ended
Adjustments for currency translation are calculated by translating data of the current and comparative periods using a budget foreign exchange rate that is set once a year as part of the Company's internal annual forecast process.
Adjusted and Organic non-IFRS financial information should be read in conjunction with the unaudited financial statements of
Adjusted Free Cash Flow – Adjusted free cash flow is the amount of cash generated from operating activities before cash flows related to exceptional items (as described above), non-operating M&A related costs and working capital movements on employer taxes associated with share based payment awards, but after capital expenditure (on property, plant and equipment and intangible assets), net interest paid, proceeds/(payments) on settlement of derivatives where hedge accounting is not applied and payments of lease liabilities. Adjusted free cash flow reflects cash flows that could be used for payment of dividends, repayment of debt or to fund acquisitions or other strategic objectives.
Please see on pages 8 to 17, the non-IFRS reconciliation tables attached hereto and the schedules accompanying this release for an explanation and reconciliation of the Adjusted and Organic financial information to the most directly comparable IFRS measure. The Company is unable to reconcile, without unreasonable efforts, Adjusted EPS guidance to the most directly comparable IFRS measure.
Nomad Foods Limited As Reported |
|||
Statements of Profit or Loss (unaudited) |
|||
Three months ended |
|||
|
|||
|
Three months ended |
|
Three months ended |
|
€m |
|
€m |
Revenue |
760.8 |
|
750.2 |
Cost of sales |
(553.1) |
|
(557.5) |
Gross profit |
207.7 |
|
192.7 |
Other operating expenses |
(122.6) |
|
(103.6) |
Exceptional items |
(18.4) |
|
(23.5) |
Operating profit |
66.7 |
|
65.6 |
Finance income |
6.2 |
|
2.7 |
Finance costs |
(26.7) |
|
(22.0) |
Net financing costs |
(20.5) |
|
(19.3) |
Profit before tax |
46.2 |
|
46.3 |
Taxation |
(21.5) |
|
(9.2) |
Profit for the period |
24.7 |
|
37.1 |
|
|
|
|
Basic earnings per share |
|
|
|
Weighted average shares outstanding in millions |
163.8 |
|
174.2 |
Basic earnings per share in € |
0.15 |
|
0.21 |
Diluted earnings per share |
|
|
|
Weighted average shares outstanding in millions |
164.4 |
|
174.2 |
Diluted earnings per share in € |
0.15 |
|
0.21 |
Statements of Profit or Loss (audited) |
|||
Twelve months ended |
|||
|
|||
|
Twelve months |
|
Twelve months |
|
€m |
|
€m |
Revenue |
3,044.5 |
|
2,939.7 |
Cost of sales |
(2,185.8) |
|
(2,124.4) |
Gross profit |
858.7 |
|
815.3 |
Other operating expenses |
(445.8) |
|
(391.2) |
Exceptional items |
(72.5) |
|
(48.7) |
Operating profit |
340.4 |
|
375.4 |
Finance income |
22.8 |
|
12.1 |
Finance costs |
(109.6) |
|
(66.5) |
Net financing costs |
(86.8) |
|
(54.4) |
Profit before tax |
253.6 |
|
321.0 |
Taxation |
(60.9) |
|
(71.2) |
Profit for the period |
192.7 |
|
249.8 |
|
|
|
|
Basic and diluted earnings per share in € |
1.13 |
|
1.43 |
Nomad Foods Limited As Reported |
|||
Statements of Financial Position (audited) |
|||
As at |
|||
|
|||
|
As at |
|
As at |
|
€m |
|
€m |
Non-current assets |
|
|
|
|
2,105.0 |
|
2,101.6 |
Intangibles |
2,468.2 |
|
2,457.6 |
Property, plant and equipment |
563.7 |
|
542.9 |
Other non-current assets |
7.1 |
|
8.1 |
Derivative financial instruments |
0.7 |
|
0.2 |
Deferred tax assets |
106.9 |
|
100.4 |
Total non-current assets |
5,251.6 |
|
5,210.8 |
Current assets |
|
|
|
Cash and cash equivalents |
412.9 |
|
369.7 |
Inventories |
446.4 |
|
457.1 |
Trade and other receivables |
263.4 |
|
261.7 |
Current tax receivable |
40.7 |
|
5.1 |
Indemnification assets |
0.5 |
|
1.8 |
Derivative financial instruments |
1.2 |
|
19.9 |
Total current assets |
1,165.1 |
|
1,115.3 |
Total assets |
6,416.7 |
|
6,326.1 |
Current liabilities |
|
|
|
Trade and other payables |
769.8 |
|
695.4 |
Current tax payable |
189.5 |
|
183.0 |
Provisions |
35.1 |
|
36.1 |
Loans and borrowings |
21.4 |
|
22.6 |
Derivative financial instruments |
12.2 |
|
3.7 |
Total current liabilities |
1,028.0 |
|
940.8 |
Non-current liabilities |
|
|
|
Loans and borrowings |
2,113.7 |
|
2,142.3 |
Employee benefits |
158.3 |
|
132.1 |
Other non-current liabilities |
0.5 |
|
1.1 |
Provisions |
1.4 |
|
1.3 |
Derivative financial instruments |
97.8 |
|
56.6 |
Deferred tax liabilities |
425.1 |
|
445.7 |
Total non-current liabilities |
2,796.8 |
|
2,779.1 |
Total liabilities |
3,824.8 |
|
3,719.9 |
Net assets |
2,591.9 |
|
2,606.2 |
Equity attributable to equity holders |
|
|
|
Share capital and capital reserve |
1,426.1 |
|
1,596.7 |
Share based compensation reserve |
31.4 |
|
13.8 |
Translation reserve |
101.0 |
|
89.3 |
Other reserves |
(24.6) |
|
19.8 |
Retained earnings |
1,058.0 |
|
886.6 |
Total equity |
2,591.9 |
|
2,606.2 |
Nomad Foods Limited As Reported |
|||
Statements of Cash Flows (audited) |
|||
For the year ended |
|||
|
|||
|
For the Year ended |
|
For the Year ended |
|
€m |
|
€m |
Cash flows from operating activities |
|
|
|
Profit for the period |
192.7 |
|
249.8 |
Adjustments for: |
|
|
|
Exceptional items |
72.5 |
|
48.7 |
Share based payment expense |
24.1 |
|
8.1 |
Depreciation and amortization |
95.0 |
|
88.6 |
Loss on disposal and impairment of property, plant and equipment |
1.2 |
|
0.8 |
Net finance costs |
86.8 |
|
54.4 |
Taxation |
60.9 |
|
71.2 |
Operating cash flow before changes in working capital, provisions and |
533.2 |
|
521.6 |
Decrease/(increase) in inventories |
18.8 |
|
(61.7) |
Decrease/(increase) in trade and other receivables |
0.3 |
|
(38.3) |
Increase in trade and other payables |
42.1 |
|
5.6 |
Decrease in employee benefits and other provisions |
(3.2) |
|
(2.4) |
Cash generated from operations before tax and exceptional items |
591.2 |
|
424.8 |
Payments relating to exceptional items |
(67.6) |
|
(65.2) |
Receipts relating to exceptional items |
— |
|
24.4 |
Tax paid |
(92.8) |
|
(80.2) |
Net cash generated from operating activities |
430.8 |
|
303.8 |
Cash flows from investing activities |
|
|
|
Business combinations, net of cash acquired |
— |
|
0.4 |
Purchase of property, plant and equipment and intangibles |
(82.4) |
|
(79.1) |
Interest received |
5.3 |
|
— |
Redemption of investments |
0.3 |
|
— |
Cash used in investing activities |
(76.8) |
|
(78.7) |
Cash flows from financing activities |
|
|
|
Repurchase of ordinary shares |
(170.9) |
|
(26.8) |
Payments related to shares withheld for tax |
(7.1) |
|
(2.9) |
Issuance of new loan principal |
6.0 |
|
799.3 |
Repayment of loan principal |
(12.6) |
|
(916.2) |
Payment of lease liabilities |
(30.1) |
|
(26.5) |
Payment of financing fees |
(3.3) |
|
(6.5) |
Interest paid |
(93.9) |
|
(54.2) |
Payment of interest on tax relating to legacy tax audits |
(9.2) |
|
— |
(Payment)/proceeds from settlements of derivatives |
(0.4) |
|
124.8 |
Other financing cash flows |
— |
|
0.9 |
Net cash used in financing activities |
(321.5) |
|
(108.1) |
Net increase in cash and cash equivalents |
32.5 |
|
117.0 |
Cash and cash equivalents at beginning of period |
366.8 |
|
254.2 |
Effect of exchange rate fluctuations |
0.4 |
|
(4.4) |
Cash and cash equivalents at end of period* |
399.7 |
|
366.8 |
|
*Cash and cash equivalents includes bank overdrafts of €13.2 million for the year ended |
|
|||||||
Reconciliation of Non-IFRS Financial Measures |
|||||||
(In € millions, except per share data) |
|||||||
|
|||||||
The following table reconciles adjusted financial information for the three months ended |
|||||||
|
|||||||
Adjusted Statement of Profit or Loss (unaudited) |
|||||||
Three Months Ended |
|||||||
|
|||||||
€ in millions, except per share data |
As reported for the |
|
Adjustments |
|
|
|
As Adjusted for the |
Revenue |
760.8 |
|
— |
|
|
|
760.8 |
Cost of sales |
(553.1) |
|
— |
|
|
|
(553.1) |
Gross profit |
207.7 |
|
— |
|
|
|
207.7 |
Other operating expenses |
(122.6) |
|
5.3 |
|
(a) |
|
(117.3) |
Exceptional items |
(18.4) |
|
18.4 |
|
(b) |
|
— |
Operating profit |
66.7 |
|
23.7 |
|
|
|
90.4 |
Finance income |
6.2 |
|
(5.2) |
|
|
|
1.0 |
Finance costs |
(26.7) |
|
0.4 |
|
|
|
(26.3) |
Net financing costs |
(20.5) |
|
(4.8) |
|
(c) |
|
(25.3) |
Profit before tax |
46.2 |
|
18.9 |
|
|
|
65.1 |
Taxation |
(21.5) |
|
8.7 |
|
(d) |
|
(12.8) |
Profit for the period |
24.7 |
|
27.6 |
|
|
|
52.3 |
|
|
|
|
|
|
|
|
Weighted average shares outstanding in millions - basic |
163.8 |
|
— |
|
|
|
163.8 |
Basic earnings per share |
0.15 |
|
|
|
|
|
0.32 |
Weighted average shares outstanding in millions - diluted |
164.4 |
|
— |
|
|
|
164.4 |
Diluted earnings per share |
0.15 |
|
|
|
|
|
0.32 |
|
|
(a) |
Share based payment charge including employer payroll taxes of €5.1 million and a non-operating M&A related credit of €0.2 million. |
(b) |
Exceptional items which management believes will only recur over a limited number of financial periods based in most cases on the completion of the particular project or program, and do not have a continuing impact. See table 'Adjusted EBITDA (unaudited) three months ended |
(c) |
Elimination of €4.9 million of foreign exchange translation gains, €0.3 million of interest income on legacy tax audits and €0.4 million of charges relating to the repricing of debt. |
(d) |
Tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. |
|
|||
Reconciliation of Non-IFRS Financial Measures (continued) |
|||
|
|||
The following table reconciles Adjusted EBITDA for the three months ended |
|||
|
|||
Adjusted EBITDA (unaudited) |
|||
Three Months Ended |
|||
|
|||
€ in millions |
As reported for the |
|
|
Profit for the period |
24.7 |
|
|
Taxation |
21.5 |
|
|
Net financing costs |
20.5 |
|
|
Depreciation and amortization |
26.2 |
|
|
Exceptional items: |
|
|
|
Business Transformation Program |
16.6 |
|
(a) |
|
2.8 |
|
(b) |
Settlement of legacy matters |
(1.0) |
|
(c) |
Other Adjustments: |
|
|
|
Other add-backs |
5.3 |
|
(d) |
Adjusted EBITDA (e) |
116.6 |
|
|
|
|
(a) |
Expenses associated with the multi-year, enterprise-wide transformation and optimization program. Expenses in the period consist of restructuring, severance and transformational project costs, including business technology transformation initiative costs and related professional fees. |
(b) |
Expenses associated with the integration of the |
(c) |
Income and expenses associated with the release of acquired provisions relating to periods prior to acquisition by the Company and other gains or charges associated with items that were originally recognized as exceptional. |
(d) |
Represents the elimination of share based payment charge including employer payroll taxes of €5.1 million and elimination of a non-operating M&A related credit of €0.2 million. |
(e) |
Adjusted EBITDA margin of 15.3% for the three months ended |
|
|||||||
Reconciliation of Non-IFRS Financial Measures (continued) |
|||||||
|
|||||||
The following table reconciles Adjusted financial information for the three months ended |
|||||||
|
|||||||
Adjusted Statements of Profit or Loss (unaudited) |
|||||||
Three Months Ended |
|||||||
|
|||||||
€ in millions, except per share data |
As reported for the |
|
Adjustments |
|
|
|
As Adjusted for the |
Revenue |
750.2 |
|
— |
|
|
|
750.2 |
Cost of sales |
(557.5) |
|
— |
|
|
|
(557.5) |
Gross profit |
192.7 |
|
— |
|
|
|
192.7 |
Other operating expenses |
(103.6) |
|
1.1 |
|
(a) |
|
(102.5) |
Exceptional items |
(23.5) |
|
23.5 |
|
(b) |
|
— |
Operating profit |
65.6 |
|
24.6 |
|
|
|
90.2 |
Finance income |
2.7 |
|
(2.3) |
|
|
|
0.4 |
Finance costs |
(22.0) |
|
3.1 |
|
|
|
(18.9) |
Net financing costs |
(19.3) |
|
0.8 |
|
(c) |
|
(18.5) |
Profit before tax |
46.3 |
|
25.4 |
|
|
|
71.7 |
Taxation |
(9.2) |
|
(4.8) |
|
(d) |
|
(14.0) |
Profit for the period |
37.1 |
|
20.6 |
|
|
|
57.7 |
|
|
|
|
|
|
|
|
Weighted average shares outstanding in millions - basic |
174.2 |
|
— |
|
|
|
174.2 |
Basic earnings per share |
0.21 |
|
|
|
|
|
0.33 |
Weighted average shares outstanding in millions - diluted |
174.2 |
|
— |
|
|
|
174.2 |
Diluted earnings per share |
0.21 |
|
|
|
|
|
0.33 |
|
|
(a) |
Share based payment charge including employer payroll taxes of €1.2 million and a non-operating M&A related credit of €0.1 million. |
(b) |
Exceptional items which management believes will only recur over a limited number of financial periods based in most cases on the completion of the particular project or program, and do not have a continuing impact. See table 'Adjusted EBITDA (unaudited) three months ended |
(c) |
Elimination of a €2.3 million net gain from refinancing activities, €1.6 million of foreign exchange translation losses and €1.5 million of foreign exchange losses on derivatives. |
(d) |
Tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. |
|
|||
Reconciliation of Non-IFRS Financial Measures (continued) |
|||
|
|||
The following table reconciles Adjusted EBITDA for the three months ended |
|||
|
|||
Adjusted EBITDA (unaudited) |
|||
Three Months Ended |
|||
|
|||
€ in millions |
As reported for the |
|
|
Profit for the period |
37.1 |
|
|
Taxation |
9.2 |
|
|
Net financing costs |
19.3 |
|
|
Depreciation and amortization |
22.8 |
|
|
Exceptional items: |
|
|
|
Findus Switzerland integration costs |
0.7 |
|
(a) |
Impairment of customer relationships |
5.8 |
|
(b) |
Information Technology Transformation program |
0.6 |
|
(c) |
Business Transformation Program |
10.9 |
|
(d) |
Distribution network integration |
1.6 |
|
(e) |
|
4.0 |
|
(f) |
Factory optimization |
0.9 |
|
(g) |
Settlement of legacy matters |
(1.0) |
|
(h) |
Other Adjustments: |
|
|
|
Other add-backs |
1.1 |
|
(i) |
Adjusted EBITDA (j) |
113.0 |
|
|
|
|
(a) |
Expenses associated with the integration of the Findus Switzerland business acquired on |
(b) |
Charge for the impairment of our food service customer relationships in |
(c) |
Expenses associated with the Information Technology Transformation program, which are primarily professional fees. |
(d) |
Expenses associated with the multi-year, enterprise-wide transformation and optimization program. Expenses in the period consisted of restructuring and transformational project costs, including business technology transformation initiative costs and related professional fees. |
(e) |
Expenses associated with the restructuring of the sales operations in northern |
(f) |
Expenses associated with the integration of the |
(g) |
Expenses associated with a three-year factory optimization program, initiated in 2018, to develop a new suite of standard manufacturing and supply chain processes, that will provide a single network of optimized factories. Due to delays in delivering the program, it was extended for an additional year and completed in 2022. |
(h) |
Income and expenses associated with the release of acquired provisions relating to periods prior to acquisition by the Company and other gains or charges associated with items that were originally recognized as exceptional. |
(i) |
Represents the elimination of share based payment charge including employer payroll taxes of €1.2 million and elimination of a non-operating M&A related credit of €0.1 million. |
(j) |
Adjusted EBITDA margin of 15.1% for the three months ended |
|
|||||||
Reconciliation of Non-IFRS Financial Measures (continued) |
|||||||
|
|||||||
The following table reconciles adjusted financial information for the twelve months ended |
|||||||
|
|||||||
Adjusted Statement of Profit or Loss (unaudited) |
|||||||
Twelve Months Ended |
|||||||
|
|||||||
€ in millions, except per share data |
As reported for the |
|
Adjustments |
|
|
|
As Adjusted for the |
Revenue |
3,044.5 |
|
— |
|
|
|
3,044.5 |
Cost of sales |
(2,185.8) |
|
— |
|
|
|
(2,185.8) |
Gross profit |
858.7 |
|
— |
|
|
|
858.7 |
Other operating expenses |
(445.8) |
|
27.1 |
|
(a) |
|
(418.7) |
Exceptional items |
(72.5) |
|
72.5 |
|
(b) |
|
— |
Operating profit |
340.4 |
|
99.6 |
|
|
|
440.0 |
Finance income |
22.8 |
|
(17.0) |
|
|
|
5.8 |
Finance costs |
(109.6) |
|
7.5 |
|
|
|
(102.1) |
Net financing costs |
(86.8) |
|
(9.5) |
|
(c) |
|
(96.3) |
Profit before tax |
253.6 |
|
90.1 |
|
|
|
343.7 |
Taxation |
(60.9) |
|
(8.0) |
|
(d) |
|
(68.9) |
Profit for the period |
192.7 |
|
82.1 |
|
|
|
274.8 |
|
|
|
|
|
|
|
|
Weighted average shares outstanding in millions - basic |
170.6 |
|
— |
|
|
|
170.6 |
Basic earnings per share |
1.13 |
|
|
|
|
|
1.61 |
Weighted average shares outstanding in millions - diluted |
171.2 |
|
— |
|
|
|
171.2 |
Diluted earnings per share |
1.13 |
|
|
|
|
|
1.61 |
|
|
(a) |
Share based payment charge including employer payroll taxes of €26.1 million and non-operating M&A related costs of €1.0 million. |
(b) |
Exceptional items which management believes will only recur over a limited number of financial periods based in most cases on the completion of the particular project or program, and do not have a continuing impact. See table 'Adjusted EBITDA (unaudited) twelve months ended |
(c) |
Elimination of €16.7 million of net gains on repricing of debt, €3.5 million of interest cost on tax relating to legacy tax audits, €3.0 million of foreign exchange translation losses, €1.0 million of losses on derivatives and a €0.3 million gain from the reversal of an impairment loss on a short-term investment. |
(d) |
Tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. |
|
|||
Reconciliation of Non-IFRS Financial Measures (continued) |
|||
|
|||
The following table reconciles Adjusted EBITDA for the twelve months ended |
|||
|
|||
Adjusted EBITDA (unaudited) |
|||
Twelve Months Ended |
|||
|
|||
€ in millions |
For the twelve |
|
|
Profit for the period |
192.7 |
|
|
Taxation |
60.9 |
|
|
Net financing costs |
86.8 |
|
|
Depreciation and amortization |
95.0 |
|
|
Exceptional items: |
|
|
|
Information Technology Transformation program |
0.6 |
|
(a) |
Business Transformation Program |
68.4 |
|
(b) |
|
4.3 |
|
(c) |
Settlement of legacy matters |
(0.8) |
|
(d) |
Other Adjustments: |
|
|
|
Other add-backs |
27.1 |
|
(e) |
Adjusted EBITDA (f) |
535.0 |
|
|
|
|
(a) |
Expenses associated with the Information Technology Transformation program, which are primarily professional fees. The program was completed in 2023. |
(b) |
Expenses associated with the multi-year, enterprise-wide transformation and optimization program which began in 2020. Expenses in the period consist of restructuring, severance and transformational project costs, including business technology transformation initiative costs and related professional fees. |
(c) |
Expenses associated with the integration of the |
(d) |
Income and expenses associated with the release of acquired provisions relating to periods prior to acquisition by the Company and other gains or charges associated with items that were originally recognized as exceptional. |
(e) |
Represents the elimination of share based payment charge including employer payroll taxes of €26.1 million and elimination of non-operating M&A related costs of €1.0 million. |
(f) |
Adjusted EBITDA margin of 17.6% for the twelve months ended |
|
|||||||
Reconciliation of Non-IFRS Financial Measures (continued) |
|||||||
|
|||||||
The following table reconciles Adjusted financial information for the twelve months ended |
|||||||
|
|||||||
Adjusted Statements of Profit or Loss (unaudited) |
|||||||
Twelve Months Ended |
|||||||
|
|||||||
€ in millions, except per share data |
As reported for the |
|
Adjustments |
|
|
|
As Adjusted for the |
Revenue |
2,939.7 |
|
— |
|
|
|
2,939.7 |
Cost of sales |
(2,124.4) |
|
— |
|
|
|
(2,124.4) |
Gross profit |
815.3 |
|
— |
|
|
|
815.3 |
Other operating expenses |
(391.2) |
|
11.7 |
|
(a) |
|
(379.5) |
Exceptional items |
(48.7) |
|
48.7 |
|
(b) |
|
— |
Operating profit |
375.4 |
|
60.4 |
|
|
|
435.8 |
Finance income |
12.1 |
|
(11.5) |
|
|
|
0.6 |
Finance costs |
(66.5) |
|
— |
|
|
|
(66.5) |
Net financing costs |
(54.4) |
|
(11.5) |
|
(c) |
|
(65.9) |
Profit before tax |
321.0 |
|
48.9 |
|
|
|
369.9 |
Taxation |
(71.2) |
|
(5.3) |
|
(d) |
|
(76.5) |
Profit for the period |
249.8 |
|
43.6 |
|
|
|
293.4 |
|
|
|
|
|
|
|
|
Weighted average shares outstanding in millions - basic |
174.3 |
|
— |
|
|
|
174.3 |
Basic earnings per share |
1.43 |
|
|
|
|
|
1.68 |
Weighted average shares outstanding in millions - diluted |
174.3 |
|
— |
|
|
|
174.3 |
Diluted earnings per share |
1.43 |
|
|
|
|
|
1.68 |
|
|
(a) |
Share based payment charge including employer payroll taxes of €8.6 million and non-operating M&A related costs of €3.1 million. |
(b) |
Exceptional items which management believes will only recur over a limited number of financial periods based in most cases on the completion of the particular project or program, and do not have a continuing impact. See table 'Adjusted EBITDA (unaudited) twelve months ended |
(c) |
Elimination of €2.3 million of net gain recognized as part of refinancing activities and €9.2 million of foreign exchange translation gains. |
(d) |
Tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises. |
|
|||
Reconciliation of Non-IFRS Financial Measures (continued) |
|||
|
|||
The following table reconciles Adjusted EBITDA for the twelve months ended |
|||
|
|||
Adjusted EBITDA (unaudited) |
|||
Twelve Months Ended |
|||
|
|||
€ in millions |
For the twelve |
|
|
Profit for the period |
249.8 |
|
|
Taxation |
71.2 |
|
|
Net financing costs |
54.4 |
|
|
Depreciation and amortization |
88.6 |
|
|
Exceptional items: |
|
|
|
Findus Switzerland integration costs |
8.2 |
|
(a) |
Impairment of customer relationships |
5.8 |
|
(b) |
Information Technology Transformation program |
4.4 |
|
(c) |
Business Transformation Program |
37.0 |
|
(d) |
Distribution network integration |
2.2 |
|
(e) |
|
9.5 |
|
(f) |
Factory optimization |
3.5 |
|
(g) |
Settlement of legacy matters |
(28.9) |
|
(h) |
Release of indemnification assets |
7.0 |
|
(i) |
Other Adjustments: |
|
|
|
Other add-backs |
11.7 |
|
(j) |
Adjusted EBITDA (k) |
524.4 |
|
|
|
|
(a) |
Expenses associated with the integration of the Findus Switzerland business acquired on |
(b) |
Charge for the impairment of our food service customer relationships in |
(c) |
Expenses associated with the Information Technology Transformation program, which are primarily professional fees. |
(d) |
Expenses associated with the multi-year, enterprise-wide transformation and optimization program which began in 2020. Expenses in the period consist of restructuring and transformational project costs, including business technology transformation initiative costs and related professional fees. |
(e) |
Expenses associated with the restructuring of the sales operations in northern |
(f) |
Expenses associated with the integration of the |
(g) |
Expenses associated with a three-year factory optimization program, initiated in 2018, to develop a new suite of standard manufacturing and supply chain processes, that will provide a single network of optimized factories. Due to delays in delivering the program, it was extended for an additional year and completed in 2022. |
(h) |
Income and expenses associated with the release of acquired provisions relating to periods prior to acquisition by the Company and other gains or charges associated with items that were originally recognized as exceptional. |
(i) |
Charge for the release of shares held in escrow as part of the consideration on the acquisition of the |
(j) |
Represents the elimination of share based payment charge including employer payroll taxes of €8.6 million and elimination of non-operating M&A related costs of €3.1 million. |
(k) |
Adjusted EBITDA margin of 17.8% for the twelve months ended |
|
|||||
Adjusted Financial Information (continued) |
|||||
|
|||||
Appendix 1: Reconciliation from reported to organic revenue growth/(decline) |
|||||
|
|||||
Year on Year Growth - |
|||||
|
|||||
|
Three Months Ended |
|
Twelve Months Ended |
|
|
|
YoY change |
|
YoY change |
|
|
Reported Revenue Growth |
1.4 % |
|
3.6 % |
|
|
|
|
|
|
|
|
Of which: |
|
|
|
|
|
Organic Revenue Growth/(Decline) |
1.9 % |
|
4.9 % |
|
|
Translational FX (a) |
(0.5) % |
|
(1.3) % |
|
|
Total |
1.4 % |
|
3.6 % |
|
|
|
|
(a) |
Translational FX is calculated by translating data of the current and comparative periods using a budget foreign exchange rate that is set once a year as part of the Company's internal annual forecast process. |
|
|
Adjusted Financial Information (continued) |
|
|
|
Appendix 2: Reconciliation from reported net cash flows from operating activities to Adjusted free cash flow |
|
|
|
The following table is a reconciliation of reported net cash flows from operating activities to Adjusted free cash flow for the year ended |
|
|
|
Reconciliation of net cash flows from operating activities to Adjusted free cash flow (unaudited) |
|
Twelve Months Ended |
|
|
|
€ in millions |
Twelve months ended |
Net Cash Flows From Operating Activities |
430.8 |
Add back: |
|
Cash flows relating to exceptional items (a) |
67.6 |
Employer taxes related to share based payments (b) |
2.0 |
Non-operating M&A costs (c) |
1.0 |
Deduct: |
|
Capital expenditure (d) |
(82.4) |
Net interest paid |
(88.6) |
Other financing cash flows |
(0.4) |
Payment of lease liabilities (e) |
(30.1) |
Adjusted free cash flow |
299.9 |
|
|
Adjusted profit for the period |
274.8 |
Adjusted free cash flow as % adjusted profit for the period |
109 % |
|
|
(a) |
Adjustment to add back cash flows related to exceptional items which are not considered to be indicative of our ongoing operating cash flows. |
(b) |
Adjustment to add back working capital movements related to employer taxes related to share based payments which are not considered to be indicative of our ongoing operating cash flows. |
(c) |
Adjustment to add back cash flows related to non-operating M&A costs which are not considered to be indicative of our ongoing operating cash flows. |
(d) |
Defined as the sum of property, plant and equipment and intangible assets purchased in the year, which are considered part of the underlying business cash flows. |
(e) |
These lease liabilities are included in Net Cash Flows from Financing Activities. We believe these payments are part of the underlying business cash flows and should be reflected in Adjusted free cash flow. |
Forward-Looking Statements
Forward-Looking Statements and Disclaimers
Certain statements in this announcement are forward-looking statements which are based on the Company's expectations, intentions and projections regarding its future performance, anticipated events or trends and other matters that are not historical facts, including the Company's expectations regarding (i) its future operating and financial performance, including its reiterated guidance with respect to organic net revenue growth, Adjusted EBITDA growth, free cash flow conversion, Adjusted EPS, and Adjusted EPS growth for 2024; (ii) its ability to generate stronger bottom-line growth and superior shareholder returns; and (iii) its success in 2024 and beyond.
These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including: (i) the Company's ability to effectively mitigate factors that negatively impact its supply of raw materials, including the conflict in
No Offer or Solicitation
This release and referenced conference call is provided for informational purposes only and does not constitute an offer to sell, or an invitation to subscribe for, purchase or exchange, any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance, exchange or transfer of the securities referred to in this press release in any jurisdiction in contravention of applicable law.
The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe such restrictions.
View original content:https://www.prnewswire.com/news-releases/nomad-foods-reports-fourth-quarter-and-full-year-2023-financial-results-302075039.html
SOURCE